About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 37 record(s)
Req # A-2021-09955
Copy of the French version of the February 9, 2021 communication plan titled "Modern and Proactive Communications Strategy".Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11663
A copy of the release package that was disclosed in response to access to information request file number A-2021-007891.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11666
A copy of the PMPRB's 6-page Communication Plan, "Modern and Proactive Communications Strategy", dated February 9, 2021 as previously disclosed in a release package in response to an access to information request.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11668
Copies of the email chain between Michell Levine, Isabel Jaen Raasch, Tanya Potashnik, Douglas Clark, Guillaume Couillard, Riaz Awadia and Elena Lungu having the subject line "Call with IMC this morning", dated December 5, 2019.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back…Organization: Patented Medicine Prices Review Board Canada
September 2020